GB9324167D0 - Synergistic combination to improve the secretion of endogenous growth hormone - Google Patents

Synergistic combination to improve the secretion of endogenous growth hormone

Info

Publication number
GB9324167D0
GB9324167D0 GB939324167A GB9324167A GB9324167D0 GB 9324167 D0 GB9324167 D0 GB 9324167D0 GB 939324167 A GB939324167 A GB 939324167A GB 9324167 A GB9324167 A GB 9324167A GB 9324167 D0 GB9324167 D0 GB 9324167D0
Authority
GB
United Kingdom
Prior art keywords
secretion
improve
growth hormone
synergistic combination
endogenous growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939324167A
Other versions
GB2273046A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9324167D0 publication Critical patent/GB9324167D0/en
Publication of GB2273046A publication Critical patent/GB2273046A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9324167A 1992-12-02 1993-11-24 Synergistic combination to improve secretion of endogenous growth hormone Withdrawn GB2273046A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98460192A 1992-12-02 1992-12-02

Publications (2)

Publication Number Publication Date
GB9324167D0 true GB9324167D0 (en) 1994-01-12
GB2273046A GB2273046A (en) 1994-06-08

Family

ID=25530690

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9324167A Withdrawn GB2273046A (en) 1992-12-02 1993-11-24 Synergistic combination to improve secretion of endogenous growth hormone

Country Status (1)

Country Link
GB (1) GB2273046A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120955A0 (en) * 1997-05-30 1997-09-30 Univ Ramot Treatment of osteoporosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone

Also Published As

Publication number Publication date
GB2273046A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
GB2116980B (en) Human growth hormone variants
PL321590A1 (en) Compounds capable to cause liberation of the growth hormone
HK1094148A1 (en) Synergistic therapeutic compositions and methods
SG66224A1 (en) Stabilized retinoid-containing skin care compositions
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
GB9206492D0 (en) Wound healing composition
JPS6434980A (en) Piperidine-triazine compound and use as stabilizer
GB2273868B (en) Improvements relating to surgical tables
GB9323124D0 (en) Novel benzo-fused lactams inhibit the release of growth hormone
HUT47395A (en) Composition against protozoosis of insects
GB9100217D0 (en) Deicing compositions
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
NZ219605A (en) Cyclopropane derivatives and fungicidal compositions
GB9324167D0 (en) Synergistic combination to improve the secretion of endogenous growth hormone
IL104132A0 (en) Compositions for the treatment of mammalian diseases
AU1122088A (en) Improvements in the inhibition of lice
ZA893745B (en) Stabilized fat compositions
GB9222012D0 (en) Improvements relating to the treatment of haemophilia
AU2632088A (en) Improvements in the inhibition of lice
AU3406389A (en) Synergistic combinations of beta-mimetic compounds and PAF-antagonists and their use as therapeutic agents
GB2301282B (en) Improvements relating to surgical tables
GB2198643B (en) Increasing endogenous growth hormone
IL90196A0 (en) Agents for enhancing the growth of livestock
GB8516791D0 (en) Testosterone esters & injectable therapeutic compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)